Performance Enhancing Drugs are leading the sports nowadays, and most athletes consider themselves incomplete without them. Markets are full of anabolic steroids that claim to improve the power and performance of athletes. However, there are few anabolic steroids that are leading the PED’s such as Winstrol pills that can undoubtedly enhance strength and performance especially in bodybuilding. In this article, we will take a view of Winstrol pills and its effectiveness.
Winstrol and Winstrol Depot are the trade names under which Winthrop Laboratories sell the synthetic anabolic steroid Stanozolol originally introduced by them in USA in 1962. At nearly the same time, Bayer presented the drug in Europe under the trade name Stromba. Being an anabolic steroid it is claimed to have effectiveness in osteoporosis (both due to age and due to menopause), dwarfism due to lack of pituitary hormone and a plastic anemia. Also claimed was its ability to promote body tissue and to inhibit tissue atrophy in certain malignant and nonmalignant conditions. It was also supported by use for infants, elderly persons, and vulnerable patients undergoing surgery or recovering from surgery or prolonged illness. It seems to have such wide-ranging advantages and so much was claimed about it that it appeared like a magic drug.
Use in Humans
In the same year as, the drug was introduced the FDA was given powers to probe into evidence of effectiveness of drugs before those were allowed in the market. The findings of FDA about Winstrol (Stanozolol) were not very favorable. Efficiency in build of body tissue and prevention thereof was not established. The same was true for benefits claimed in an extensive list of diseases including children’s nutritional disorders, carcinoma of the prostate gland. Benefit to chronically ill or malnourished individuals was also not established clearly. Since no other medicines were available for osteoporosis and dwarfism, FDA allowed, as an interim decision, continued use of Stanozolol only as an adjunct treatment for these disorders. When human growth hormone drugs became, available FDA disallowed the mention of dwarfism on the label on Winstrol. Further evidence submitted by the company did not satisfy FDA, and permission to claim benefit in osteoporosis and aplastic anemia was also withdrawn. Anabolic steroids including Stanozolol had been commonly used to treat hereditary angioedema attacks, but their use was discontinued when several drugs specifically for that disease became available starting 2009. Stanozolol is still an option in the long term to reduce the severity and frequency of attacks in humans, and perhaps, that may be the only legal use of this drug for humans, and again subject to a prescription by a practitioner.
Currently, Winstrol is used as an adjunct medicine for veterinary use. Possible uses are against wasting diseases, to promote red blood cell formation, to increase appetite, enhance density of bones, and to help in bulk gain. It is also used as a performance-enhancing drug in race horses. The evidence for these uses is also said to be weak and debatable.
Side Effects of Misuse
Use of Winstrol may be accompanied by unintended weight gain, excessive retention of water, and possible difficulty in getting rid of nitrogen waste products. It may cause harm to the liver. Toxicity to liver has been especially noted in cats. Its use has shown some correlation with growth of tumors, and as a result, it is not advised in case of dogs with enlarged prostates.